企業プロフィール
Syros Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- SYRS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (+300.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
As of Aug 17, 2026, SYRS closed up 300.0% at $0.0004. No new same-company headline was identified in the current news window.
企業概要
事業概要
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Syros sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, target validation, and the ability to create a durable oncology story.
バイオ業界での位置付け
Syros is a small-cap oncology catalyst name whose valuation depends on early data and strategic progress.
今後のカタリスト
- Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。